CROTF (CROTF)

Crocs (NASDAQ:CROX - Get Free Report) announced its quarterly earnings data on Thursday. The textile maker reported $4.55 EPS for the quarter, topping analysts' consensus estimates of $4.35 by $0.20. Crocs had a negative net margin of 2.58% and a positive return on equity of 48.29%. The company ...

Corcept Therapeutics Incorporated stocks have been trading up by 28.11 percent following highly positive clinical progress news. Key Takeaways Q2 from Corcept Therapeutics crushed expectations, with EPS at $0.36 vs. $0.05 and revenue at $256.1M vs. $220.1M, plus higher 2026 guidance to $1.1–$1.2B.

Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.

Crocs said second-quarter adjusted ... marketplace sales. The footwear maker reported adjusted earnings of $4.55 a share on revenue of $1.18 billion, compared with forecasts for $4.32 a share and $1.15 billion. The stock was last down 12.06% at $117.42, versus a previous close ...

Crocs, Inc. (NASDAQ:CROX) shares fell almost 10% on Thursday after the footwear company issued a weaker-than-expected third quarter outlook, as tariff...